- Home
- NVCR vs VRTS Comparison
NVCR vs VRTS Comparison
Compare NVCR & VRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- VRTS
- Stock Information
- Founded
- NVCR 2000
- VRTS 1988
- Country
- NVCR Switzerland
- VRTS United States
- Employees
- NVCR N/A
- VRTS N/A
- Industry
- NVCR Medical/Dental Instruments
- VRTS Investment Managers
- Sector
- NVCR Health Care
- VRTS Finance
- Exchange
- NVCR Nasdaq
- VRTS Nasdaq
- Market Cap
- NVCR 1.4B
- VRTS 1.3B
- IPO Year
- NVCR 2015
- VRTS 1992
- Fundamental
- Price
- NVCR $13.77
- VRTS $166.99
- Analyst Decision
- NVCR Buy
- VRTS Hold
- Analyst Count
- NVCR 7
- VRTS 4
- Target Price
- NVCR $28.79
- VRTS $184.25
- AVG Volume (30 Days)
- NVCR 1.6M
- VRTS 84.4K
- Earning Date
- NVCR 10-30-2025
- VRTS 10-24-2025
- Dividend Yield
- NVCR N/A
- VRTS 5.75%
- EPS Growth
- NVCR N/A
- VRTS 18.44
- EPS
- NVCR N/A
- VRTS 19.47
- Revenue
- NVCR $630,160,000.00
- VRTS $878,336,000.00
- Revenue This Year
- NVCR $6.68
- VRTS N/A
- Revenue Next Year
- NVCR $7.01
- VRTS $1.20
- P/E Ratio
- NVCR N/A
- VRTS $8.57
- Revenue Growth
- NVCR 14.58
- VRTS N/A
- 52 Week Low
- NVCR $10.87
- VRTS $142.18
- 52 Week High
- NVCR $34.13
- VRTS $252.82
- Technical
- Relative Strength Index (RSI)
- NVCR 51.39
- VRTS 28.67
- Support Level
- NVCR $13.57
- VRTS $175.00
- Resistance Level
- NVCR $14.58
- VRTS $185.94
- Average True Range (ATR)
- NVCR 0.64
- VRTS 6.77
- MACD
- NVCR -0.05
- VRTS -1.83
- Stochastic Oscillator
- NVCR 49.59
- VRTS 19.52
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About VRTS Virtus Investment Partners Inc.
Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.